Determinants of response to insulin therapy following failure of oral agents in type 2 diabetes

Diabetes Care

Volumn 28, Issue 10, 2005, Pages 2589-2590

  Karalliedde, Janaka ^a   Smith, Andy ^a   Viberti, Giancarlo ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ARTICLE; BODY MASS; DRUG DOSE REGIMEN; DRUG DOSE REQUIREMENT; DRUG RESPONSE; ETHNIC DIFFERENCE; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; TREATMENT FAILURE; WEIGHT GAIN;

ADMINISTRATION, ORAL; DIABETES MELLITUS, TYPE 2; DRUG RESISTANCE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 25644452839     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.10.2589     Document Type: Article

References (3)

1. Yki-Jarvinen H, Ryysy L, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Rajala S, Salo S, Seppala P, Tulokas T, Viikari J, Taskinen MR: Effect of obesity on response to insulin therapy in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:4037-4043, 1997
2. Argawal L, Emanuele NV, Abraira C, Henderson WG, Levin SR, Sawin CT, Silbert CK, Nuttall FQ, Comstock JP, Colwel JA: Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Diabetes Care 21:510-515, 1998
3. Aviles-Santa L, Sinding J, Raskin P: Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 131:182-188, 1999